In a report released today, Graham Doyle from UBS maintained a Hold rating on Carl Zeiss Meditec (0DHC – Research Report), with a price target of €50.00. The company’s shares closed ...
European shares see off week lower as rising yields, L'Oreal losses weigh February 9, 2024 German medical technology firm Carl Zeiss Meditec said on Friday it had bought the Dutch Ophthalmic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results